ANDA 71471, held by Hikma. Cytarabine.
As of Nov 16, 2026, ANDA 71471 (Cytarabine), held by Hikma, was first approved by FDA on Aug 2, 1989, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 2, 1989 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cytarabine100MG/VIAL ยท injectable;injection | Cytarabine | Rx |
| Jun 18, 2004 | Supplement 11Labeling | Approved | None posted |
| Oct 13, 2000 | Supplement 7Labeling | Approved | None posted |
| Jul 11, 1997 | Supplement 6Labeling | Approved | None posted |
| Jul 21, 1995 | Supplement 5Manufacturing | Approved | None posted |
| Oct 17, 1994 | Supplement 4Manufacturing | Approved | None posted |
| Jun 9, 1994 | Supplement 3Manufacturing | Approved | None posted |
| Sep 30, 1992 | Supplement 2Labeling | Approved | None posted |
| Dec 18, 1990 | Supplement 1Labeling | Approved | None posted |
| Aug 2, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters